HHCAX — Highland Long/Short Healthcare Fund
Data updated: 2026-06-01
HHCAX — Highland Long/Short Healthcare Fund data: holdings, portfolio allocation, expenses, performance, cashflows, risk and SEC filings. United States Health Care Equity · $78.97M AUM · 2.65% expense ratio · 1.4% 1-yr return. From SEC regulatory filings.
HHCAX Fund Overview
HHCAX — Highland Long/Short Healthcare Fund is a US mutual fund managed by Nexpoint Funds I, categorised as United States Health Care Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US mutual fund
- Manager: Nexpoint Funds I
- Category: United States Health Care Equity
- Assets under management: $78.97M
- 1-year return: 1.4%
- Ticker: HHCAX
- SEC CIK: 0001354917
- SEC series ID: S000021242
- Share class ID: C000060521
HHCAX Holdings
Top 10 holdings of Highland Long/Short Healthcare Fund by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| Southwest Gas Holdings, Inc. | 4.25% |
| Terns Pharmaceuticals Inc | 4.15% |
| Hologic, Inc. | 3.77% |
| Electronic Arts Inc. | 3.70% |
| Kyivstar Group Ltd | 3.62% |
| Lionsgate Studios Corp. | 3.62% |
| Select Medical Holdings Corporation | 3.39% |
| Warner Bros. Discovery, Inc. | 3.34% |
| James Hardie Industries Public Limited Company | 3.31% |
| Csg Systems International, Inc. | 3.24% |
HHCAX Portfolio Allocation
Asset-class allocation of Highland Long/Short Healthcare Fund by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 100.2% |
| Fixed Income | 2.0% |
| Cash & Equivalents | 2.0% |
| Derivatives | 0.2% |
HHCAX Performance
Total returns for HHCAX (as of 2026-08-01), from SEC filings.
| Period | Total return |
|---|---|
| YTD | -5.3% |
| 1 year | 1.4% |
| 3 years (annualised) | 4.2% |
| 5 years (annualised) | -2.7% |
HHCAX Risk Information
Risk metrics for HHCAX, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 13.8%
HHCAX Costs and Fees
HHCAX costs about $265 per $10,000 invested per year in fund expenses.
- Net expense ratio: 2.65%
- Gross expense ratio: 3.10%
- Portfolio turnover: 397%
- Brokerage commissions: 47.33 bps of average net assets (SEC N-CEN)
HHCAX Cashflows
Over the 12 months to 2026-03, Highland Long/Short Healthcare Fund had net outflows of $14.40M, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2026-03 | −$474.51K |
| 2026-02 | $2.59M |
| 2026-01 | −$7.13M |
| 2025-12 | $3.33M |
| 2025-11 | −$4.13M |
| 2025-10 | $1.26M |
HHCAX Debt Constituents
Largest debt holdings of Highland Long/Short Healthcare Fund by percentage of net assets, from the latest SEC N-PORT filing.
| Debt holding | % of net assets |
|---|---|
| Sealed Air Corporation | 1.33% |
| Sealed Air Corporation | 0.67% |
HHCAX Prospectus and SEC Filings
Official Highland Long/Short Healthcare Fund filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
Related Funds
Other United States Health Care Equity funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.